Navigation Links
Leading Physicians To Host Medical Device Related Infection Prevention CME Webcast
Date:11/12/2008

Rabih Darouiche, MD and Charles Love, MD to Present Live Webcast: 'New Standards of Care for CRMD Antibiotic Protection'

MONMOUTH JUNCTION, N.J., Nov. 12 /PRNewswire/ -- TYRX, Inc., a leader in the development and commercialization of combination drug-device products, announced today that it has provided a grant for a complimentary live CME webcast hosted by leading physicians entitled, "New Standards of Care for CRMD Antibiotic Protection." The Interactive Web Symposia will be presented live on November 18, 2008 at 6:00 p.m. EST and November 19, 2008 at 3:00 p.m. EST by Rabih O. Darouiche, MD and Charles J. Love, MD.

Dr. Darouiche, VA Distinguished Service Professor, Director, Center for Prostheses Infection, Baylor College of Medicine (Houston, TX), will present on the topic: "Prevention of Device-Related Infections." Dr. Love, Professor of Clinical Medicine, Division of Cardiovascular Medicine, Ohio State University Medical Center and Director, Arrhythmia Device Services and Associate Investigator, Dorothy M. Davis Heart & Lung Research Institute (Columbus, OH), will present the topic: "Current Trends in Implantable Device Infection and Management."

The program is designed to educate physicians, nurses and technologists to: address the pathogenesis of infections associated with pacemakers; and cardioverter defibrillators; assess the anti-infective efficacy of potentially preventive approaches; and describe the risks and costs associated with resolving device-related infections. Participants can register at the following web link: http://www.naccme.com/program/n-290/

"This CME program will provide participants with valuable information on a timely and important topic in the medical device and broader healthcare community," said Bill Edelman, CEO of TYRX, Inc. "The CDC estimates that approximately one million hospital acquired infections each year are associated with
'/>"/>

SOURCE TYRX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. Leading-edge body sensor could help produce sporting champions
5. Hospital Quality Info on Web Can Be Misleading
6. AT&T Establishes New Network Services for Leading Medical Liability Insurer
7. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
10. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
11. Long Term Care Insurance Gains Momentum Thanks to State Promotions, a Leading Brokerage Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... gene manipulation these sound like the ideas ... they are components of an exciting new approach ... animal models of metastatic prostate cancer, scientists at ... of Molecular Medicine and Johns Hopkins Medical Institutions ... approach that could revolutionize doctors, ability to see ...
(Date:9/17/2014)... Tidewater Physical Therapy and ... for football players and their parents at its Newport ... open at 6:30 p.m. for athletes and parents to ... and physical therapists. The workshop will start at 7 ... News Tidewater Performance Center, which features sports performance and ...
(Date:9/17/2014)... adjourns this month for the November elections, one of ... way out the chamber door will be the Sustainable ... Act of 2014. In a new commentary in the ... what he and other advocates saw as the merits ... how Medicare pays doctors will return for the next ...
(Date:9/17/2014)... The Food and Drug Administration (FDA) ... to consider: , 1. The appropriate ... 2. The potential for adverse cardiovascular outcomes ... litigation ongoing, an informally-organized litigation group subcommittee prepared a ... replacement therapy. Among others, ZKB attorney Michelle L. Kranz ...
(Date:9/17/2014)... Leading eco-friendly beauty brand , ... its new vegan and gluten-free Sugar Cane Fruit Mask. ... the results skincare testers were looking for. , ... active mask that provided results, and I think I ... Cane Fruit Mask combines Willow bark (Salix Alba extract), ...
Breaking Medicine News(10 mins):Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 3Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 2Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 3Health News:Failed Medicare payments law remains relevant 2Health News:Failed Medicare payments law remains relevant 3Health News:FDA Advisory Committee Holds Hearing on Testosterone Safety 2Health News:EcoBeauty Brand Lotus Moon Unveils New Gluten-Free Sugar Cane Fruit Mask 2
... , March 11 As reported in today,s ... Americans with atrial fibrillation are now on notice that the over-zealous ... are not approved by the U.S. Food and Drug Administration (FDA) ... doctors, and hospitals, decisions about treatment for their patients, heart conditions. ...
... snorting cocaine among 12-year-olds, study finds , THURSDAY, March ... inhalants to get high than marijuana, cocaine and hallucinogens ... deadly inhalants include aerosol computer cleaners, glue, hair sprays, ... can cause addiction or sudden death from cardiac arrest. ...
... sign, but exercise regimens can help, experts say , THURSDAY, ... researchers report that preseason measurements of rotator cuff strength can ... developing a shoulder injury during play. , "We found certain ... players are more likely to incur injury that requires surgery," ...
... key to more effective treatment for Alzheimer,s disease and other ... test developed at the University of Tennessee is more than ... diseases. The test, called CST -- for computerized self ... simple for medical professionals to administer and for patients to ...
... monkey babies born to mothers who had the flu while ... to those observed in human patients with schizophrenia, a study ... of North Carolina at Chapel Hill has found. The ... is the first study done with monkeys that examines the ...
... Mo. While there are many benefits of losing weight, ... During weight loss, bones are being remodeled - breaking down ... rate. As a result, bone density is reduced, causing increased ... that weight-bearing exercise, in this case, fast walking or jogging, ...
Cached Medicine News:Health News:Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation 2Health News:Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation 3Health News:Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation 4Health News:Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation 5Health News:Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation 6Health News:Inhalant Abuse a Deadly Middle-School Concern 2Health News:Pre-Season Test Spots Baseball Pitchers at Risk of Injury 2Health News:Pre-Season Test Spots Baseball Pitchers at Risk of Injury 3Health News:New Alzheimer's test offers better opportunities for early detection 2Health News:Mother's flu during pregnancy may increase baby's risk of schizophrenia 2Health News:Weight-bearing exercise does not prevent increased bone turnover during weight loss 2
(Date:9/17/2014)... An analysis done by the CVS Health ... a new and expensive treatment for Hepatitis C introduced ... several months (May through August 2014) there has been ... This suggests another surge of patients will begin therapy ... efficacy and shorter duration are introduced in the Fall. ...
(Date:9/17/2014)... Utah , Sept. 17, 2014  NuView ... exclusive global licensing and collaboration agreement with Otsuka ... commercialize NuView,s investigative genomic-based diagnostic biomarker to detect ... also includes all other future diagnostic-imaging applications. NuView ... in-vivo therapeutic delivery and in-vitro urine screen applications. ...
(Date:9/17/2014)... LAWRENCEVILLE, N.J. , Sept. 17, 2014 /PRNewswire-USNewswire/ ... that details how to implement GS1 Standards to ... (DSCSA), and enhance patient safety and security in ... Applying GS1 Standards to U.S. Pharmaceutical Supply ... Chain Security Act , was developed in ...
Breaking Medicine Technology:CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 2CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 3CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 4NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 2NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 3NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 4NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 5New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 2New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 3New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 4
... - Opexa,Therapeutics, Inc. (NASDAQ:OPXA), a company involved ... today,announced positive top-line data in an open-label ... T-cell vaccine,Tovaxin(TM), for multiple sclerosis (MS). In ... remitting (RRMS),and secondary progressive (SPMS) subjects, Tovaxin ...
... 2007 - “In anaplastic,astrocytoma, AP 12009 as a ... Wong, M.D., Stanford,University, California, U.S.A. commented on the ... 12009, under development,by Antisense Pharma. Prof. Wong discussed ... session on central nervous system tumors,at the 43rd ...
Cached Medicine Technology:Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 2Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 3Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 4Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 5Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 3Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 4
... the most powerful isolated ESU on the market ... is the only ESU that allows the surgeon ... with a standard ES pencil. Excalibur Plus PC ... necessary voltage for smooth cutting through various impedance ...
High performance capabilities in a multipurpose generator, blended cut modes, simultaneous independent coagulation, low voltage coagulation, valleylab REM safety substantially reduces the risk of pat...
The Valleylab Surgistat II generator provides exceptional performance, reliability, and safety benefits in a compact, easy to use unit....
Lorgnette pinhole occluder...
Medicine Products: